Recruiting Scleroderma Studies in Iowa City
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis
The purpose of this study is to evaluate the efficacy, safety and tolerability of rapcabtagene autoleucel (administered once following lymphodepletion) in participants with severe refractory diffuse c...
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)
The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 24 weeks (Period 1) in adult participants with systemic sclerosis, ...
About Scleroderma Clinical Trials in Iowa City
Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.
There are currently 2 scleroderma clinical trials recruiting participants in Iowa City, IOWA. These studies are seeking a combined 166 participants. Research is being sponsored by Novartis Pharmaceuticals, Zura Bio Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Scleroderma Clinical Trials in Iowa City — FAQ
Are there scleroderma clinical trials in Iowa City?
Yes, there are 2 scleroderma clinical trials currently recruiting in Iowa City, IOWA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Iowa City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Iowa City research site will contact you about next steps.
Are clinical trials in Iowa City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Iowa City studies also compensate for your time and travel.
What scleroderma treatments are being tested?
The 2 active trials in Iowa City are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.
Data updated March 2, 2026 from ClinicalTrials.gov